ArticleJournal for immunotherapy of cancer2026
Overall survival of immunotherapy versus standard of care in chemorefractory microsatellite stable metastatic colorectal cancer: a propensity score matched analysis of 708 patients.
Guglielmo Vetere et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.